SMS alerts can make the difference between a profitable trade and a missed opportunity.
 Text “alert” to 97000 to receive our instant, reliable and free SMS alerts.

Traders and Investors,

I've got a special low float, small market cap trade idea to focus on tomorrow. It's a past winner we have alerted a few times to you in the past six months.
 
It's time to get PositiveID Corp (PSID) on your screen once again.

PSID looks ready to bounce... now. It has been in a slow and steady downtrend for over a month now, closing at $0.017 today , after it was trading well above $0.05 in June, and up around the $0.20 level back in late May.

In fact, when PSID announced a recent reverse split back in May, PSID skyrocketed from $0.03 to $0.20 for a 567% potential gain in just one day!!!

With PSID trading at $0.017, and with such a tiny market cap and float of less than $200k, we could potentially see plenty of upside to come in the near term.
 
And because of the recent news that PSID closed a $1.5 million investment, and other recent news catalysts, such as the $1.2 million revenues generated in Q1 2017, and the massive reduction in debt, we think momentum could rapidly shift for an explosive upside move.

Now there is even more to like about PSID than just the chart. The company has been releasing a lot of positive news recently which should get investors excited. 

As per the Company's recent press release, its financial performance is tracking nicely including an improvement on its gross margin. The Company also expects to exceed $5.6 million revenue for 2017, higher than in 2016.

“During the first quarter of 2017, our businesses performed solidly, reporting an increase in revenue of 25% over the prior sequential quarter, with a focus on building a strong pipeline for the remainder of 2017,” stated William J. Caragol, Chairman and CEO of PositiveID. “While the timing of delivery of vehicles in our Mobile Labs segment can affect results from one quarter to another, we are confident in our business pipeline for the second half of the year, and looking at the big picture, we expect 2017 revenues will exceed 2016 revenues of $5.6 million.”

In addition, PSID recently announced it has formed a new, wholly owned subsidiary, ExcitePCR Corporation, to own and further the development of the Firefly Dx real-time polymerase chain reaction (PCR) breadboard prototype pathogen detection system (“Firefly Dx prototype system”) to provide greater flexibility for strategic partnership and/or financing opportunities.

The Firefly Dx prototype system is designed to be a handheld, fully automated, lab quality, real-time device able to process samples and detect pathogens at the point of need (PON) or point of care (POC), faster and less expensively than existing devices.

According to BCC Research, the global POC diagnostics market is expected to grow from $19.3 billion in 2016 to $28.3 billion in 2021. The North American POC diagnostics market is expected to grow from nearly $9.7 billion in 2016 to $14.2 billion in 2021.


PositiveID Corp (PSID) is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays.

PSID operates in three segments: Mobile Labs, comprised of its E-N-G Mobile Systems (“ENG”) subsidiary; Medical Devices, comprised of its Thermomedics subsidiary; and Molecular Diagnostics, consisting of its Firefly Dx prototype system for real-time pathogen detection.

ENG designs and builds mobile laboratories, wireless support vehicles (cell-on-wheels and cell-on-light-trucks), radio frequency (“RF”) test platforms, broadcast news vehicles, and other technical vehicles. ​ENG has delivered more than 1,500 specialty vehicles to customers around the globe, including more than 400 mobile laboratories, 600 broadcast news vehicles, and more than 400 vehicles for cellular, RF, infrared, and other applications.

Thermomedics markets the FDA-cleared Caregiver® thermometer, which is a clinical grade, infrared thermometer for measurement of forehead temperature in adults, children, and infants, without contact. It delivers an oral-equivalent temperature directly from the forehead in one to two seconds. Since there is no skin contact and Caregiver does not require probe cover supplies, it reduces the risk of cross-contamination, which is an increasing concern, and saves healthcare facilities the cost of covers (as much as $0.05 to $0.10 per temperature), storage space, and waste disposal costs.

PSID is developing the Firefly Dx prototype system to be a handheld, fully automated, lab quality, real-time device able to detect pathogens at the point of need, faster and less expensively than existing devices. Firefly's applications include point-of-need, lab-quality, detection of pathogenic organisms; agricultural and food screening in both domestic sectors and developing countries; and detection of biological agents associated with weapons of mass destruction.

The Company's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), continuously and autonomously analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins.

PositiveID's Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results using real-time polymerase chain reaction (PCR) chemistry. Firefly Dx is being developed to meet the growing need in healthcare and molecular diagnostics markets by enabling hospitals, physicians and other providers to save lives and fight disease.

You can learn more about PSID at their website http://www.psidcorp.com/


According to OTCMarkets.com, PSID has a tiny market cap of less than $200k and the company just recently announced strong financial performance.

PSID has a technically oversold chart, which if history is anything to go by, we think is ready to bounce significantly higher in the short term. In fact, we believe based on the technical indicators and news catalysts, PSID could be a major gainer in the coming days/weeks.

Make sure you do your DD on PSID and be ready to play tomorrow.

 

 

Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity.